EC
EntryPoint Capital Portfolio holdings
AUM
$200M
1-Year Return
6.93%
This Quarter Return
+2.29%
1 Year Return
+6.93%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$112M
AUM Growth
+$7.22M
(+6.9%)
Cap. Flow
+$4.02M
Cap. Flow
% of AUM
3.6%
Top 10 Holdings %
Top 10 Hldgs %
3.56%
Holding
1,843
New
513
Increased
412
Reduced
455
Closed
458
Top Buys
| 1 |
Unisys
UIS
|
+$454K |
| 2 |
Sutro Biopharma
STRO
|
+$394K |
| 3 |
Agilysys
AGYS
|
+$382K |
| 4 |
Schrodinger
SDGR
|
+$371K |
| 5 |
REV Group
REVG
|
+$345K |
Top Sells
| 1 |
NextDecade
NEXT
|
+$643K |
| 2 |
American Well
AMWL
|
+$535K |
| 3 |
B. Riley Financial
RILY
|
+$524K |
| 4 |
Lexicon Pharmaceuticals
LXRX
|
+$496K |
| 5 |
Taysha Gene Therapies
TSHA
|
+$484K |
Sector Composition
| 1 | Healthcare | 20.49% |
| 2 | Industrials | 17.08% |
| 3 | Technology | 16.88% |
| 4 | Financials | 12.63% |
| 5 | Consumer Discretionary | 12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1226
SL Green Realty
SLG
$4.29B
| $10.6K | 0.01% |
192
+136
| +243% | +$7.5K |
|
1227
Adtalem Global Education
ATGE
$4.79B
| $10.5K | 0.01% |
+205
| New | +$10.5K |
|
1228
OraSure Technologies
OSUR
$238M
| $10.5K | 0.01% |
1,708
-24,008
| -93% | -$148K |
|
1229
Sweetgreen
SG
$1.03B
| $10.5K | 0.01% |
+415
| New | +$10.5K |
|
1230
Credit Acceptance
CACC
$5.8B
| $10.5K | 0.01% |
19
+9
| +90% | +$4.96K |
|
1231
Bank of New York Mellon
BK
$73.3B
| $10.4K | 0.01% |
181
-380
| -68% | -$21.9K |
|
1232
Capital One
COF
$143B
| $10.4K | 0.01% |
70
-170
| -71% | -$25.3K |
|
1233
InterContinental Hotels
IHG
$18.6B
| $10.4K | 0.01% |
98
+96
| +4,800% | +$10.1K |
|
1234
Pacific Biosciences
PACB
$366M
| $10.2K | 0.01% |
+2,713
| New | +$10.2K |
|
1235
Wells Fargo
WFC
$257B
| $10.1K | 0.01% |
175
+36
| +26% | +$2.09K |
|
1236
Leidos
LDOS
$23.1B
| $9.96K | 0.01% |
76
-603
| -89% | -$79K |
|
1237
Arcellx
ACLX
$4.03B
| $9.88K | 0.01% |
142
-508
| -78% | -$35.3K |
|
1238
Legend Biotech
LEGN
$6.18B
| $9.87K | 0.01% |
+176
| New | +$9.87K |
|
1239
A.O. Smith
AOS
$10.2B
| $9.75K | 0.01% |
109
+12
| +12% | +$1.07K |
|
1240
Day One Biopharmaceuticals
DAWN
$744M
| $9.62K | 0.01% |
+582
| New | +$9.62K |
|
1241
RELX
RELX
$82.4B
| $9.44K | 0.01% |
218
+162
| +289% | +$7.01K |
|
1242
Fresenius Medical Care
FMS
$14.6B
| $9.41K | 0.01% |
+488
| New | +$9.41K |
|
1243
Kontoor Brands
KTB
$4.29B
| $9.4K | 0.01% |
+156
| New | +$9.4K |
|
1244
Accel Entertainment
ACEL
$935M
| $9.36K | 0.01% |
794
-5,835
| -88% | -$68.8K |
|
1245
Structure Therapeutics
GPCR
$1.2B
| $9.34K | 0.01% |
218
-7,617
| -97% | -$326K |
|
1246
Thermo Fisher Scientific
TMO
$180B
| $9.3K | 0.01% |
+16
| New | +$9.3K |
|
1247
Saratoga Investment
SAR
$391M
| $9.23K | 0.01% |
398
-5,713
| -93% | -$133K |
|
1248
SharkNinja
SN
$16.4B
| $9.22K | 0.01% |
148
+110
| +289% | +$6.85K |
|
1249
Synovus
SNV
$7.13B
| $9.21K | 0.01% |
230
+12
| +6% | +$481 |
|
1250
Booz Allen Hamilton
BAH
$12.6B
| $9.2K | 0.01% |
62
-690
| -92% | -$102K |
|